Sean Park­er-backed cell ther­a­py start­up Ar­se­nal­Bio plucks Mer­ck VP as new CSO

Mer­ck’s im­muno-on­col­o­gy su­per­star Nicholas Hain­ing has been ap­point­ed CSO at Ar­se­nal­Bio, which is work­ing on an ap­proach to pro­gram­ma­ble cell ther­a­pies.

The ad­di­tion of a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER